Succinate salt of 2-((4-(1-methyl-4-(pyridin-4-yl)-1H-pyra zol-3-yl) phenoxy)methyl)quinoline

Details for Australian Patent Application No. 2007343135 (hide)

Owner Pfizer Products Inc.

Inventors Vorhoest, Patrick Robert; Proulx, Caroline

Agent Shelston IP

Pub. Number AU-A-2007343135

PCT Pub. Number WO2008/084299

Priority 60/871,260 21.12.06 US

Filing date 3 December 2007

Wipo publication date 17 July 2008

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/415 (2006.01) - 1,2-Diazoles

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

16 July 2009 PCT application entered the National Phase

  PCT publication WO2008/084299 Priority application(s): WO2008/084299

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007343139-Compounds having both angiotensin II receptor antagonism and PPARy activating activities

2007343130-Methods of vaccine administration